| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |